BGI-Shenzhen Completes Acquisition of Complete Genomics
BGI-Shenzhen (“BGI”), a leading international genomics organization based in Shenzhen, China, today announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has successfully completed the acquisition of Complete Genomics, Inc. (formerly NASDAQ: GNOM) ("Complete"), an innovative leader in accurate whole human genomic sequencing.
>> read moreBgi-Shenzhen And Complete Genomics, Inc. Receive Approval From The State Administration Of Foreign Exchange Of The Prc For Bgi-Shenzhen'S Proposed Acquisition Of Complete Genomics, Inc.
BGI-Shenzhen ("BGI") and Complete Genomics, Inc. (Nasdaq: GNOM) ("Complete") announced today that they have obtained approval from the State Administration of Foreign Exchange of the People’s Republic of China regarding BGI’s proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete.
>> read moreBgi-Shenzhen And Complete Genomics, Inc. Receive Approval From The Ministry Of Commerce Of The Prc For Bgi-Shenzhen'S Proposed Acquisition Of Complete Genomics, Inc.
BGI-Shenzhen ("BGI") and Complete Genomics, Inc. (Nasdaq: GNOM) ("Complete") announced today that they have obtained approval from the Ministry of Commerce of the People’s Republic of China regarding BGI’s proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete.
>> read moreBgi-Shenzhen And Complete Genomics, Inc. Receive Clearance From The National Development And Reform Commission Of The Prc For Bgi-Shenzhen's Proposed Acquisition Of Complete Genomics, Inc.
BGI-Shenzhen ("BGI") and Complete Genomics, Inc. (Nasdaq: GNOM) ("Complete") announced today that they have obtained clearance from the National Development and Reform Commission of the People’s Republic of China regarding BGI’s proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete.
>> read moreBgi-Shenzhen And Complete Genomics, Inc. Receive Early Termination Of Hart-Scott-Rodino Waiting Period
BGI-Shenzhen (“BGI”) and Complete Genomics, Inc. (Nasdaq: GNOM) (“Complete”) announced today that they have received early termination of the Hart-Scott-Rodino waiting period from the Federal Trade Commission (“FTC”) regarding BGI’s proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete.
>> read moreBGI-Shenzhen and Complete Genomics, Inc. Receive CFIUS Clearance for BGI-Shenzhen's Proposed Acquisition of Complete Genomics, Inc.
BGI-Shenzhen ("BGI") and Complete Genomics, Inc. (Nasdaq: GNOM) ("Complete") announced today that they have obtained clearance from the Committee on Foreign Investment in the United States ("CFIUS") regarding BGI's proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete.
>> read moreComplete Genomics Reports Third Quarter 2012 Results
Complete Genomics, Inc. (Nasdaq:GNOM), the whole human genome sequencing company, today announced financial results for its fiscal quarter ended September 30, 2012.
>> read moreComplete Genomics Announces Court's Favorable Ruling in Patent Litigation Against Illumina, Inc.
Complete Genomics, Inc. (Nasdaq:GNOM) today announced that Magistrate Judge Elizabeth D. Laporte of the U.S. District Court for the Northern District of California issued an Order granting Complete's Motion for Partial Summary Judgment of invalidity in the patent infringement lawsuit filed against Complete by Illumina, Inc.
>> read moreComplete Genomics and BGI-Shenzhen Announce Definitive Agreement to Merge
MOUNTAIN VIEW, Calif. and SHENZHEN, China, Sept. 17, 2012 -- Complete Genomics, Inc. (Nasdaq:GNOM) ("Complete"), an innovative leader in whole human genomic sequencing, and BGI-Shenzhen ("BGI"), a leading international genomics company based in Shenzhen, China, today announced that they have entered into a definitive merger agreement. Through...
>> read moreComplete Genomics Reports Second Quarter 2012 Results
Complete Genomics, Inc. (Nasdaq:GNOM), the whole human genome sequencing company, today announced financial results for its fiscal quarter ended June 30, 2012.
>> read more